Company Name LDS Lyotropic Delivery Systems Ltd. Company Founders Professor Nissim Garti  Current CEO Professor Nissim Garti  About the Company LDS is a privately owned nano and biotechnology company focusing on the development of novel liquid ...

We combine creative science and the power of nature’s building blocks to revolutionize products   Investment/ Collaboration Opportunity Highlights:   Melodea recently completed round financing led by Holmen www.holmen.com , a Swedish forest ...

Company Profile MercuRemoval developed a unique technology under the exclusive license of The Hebrew University for the removal of mercury emitted by gases of various industrial processes. MercuRemoval Ltd. was founded in 2015 within ...

Company Profile NanoAF develops, manufactures and sells coatings which prevent bacterial adhesion to surfaces. This groundbreaking technology allows manufacturers of medical devices, water solutions, and food packaging to prevent bacterial ...

AT A GLANCE Established by Integra Holdings in 2017, Nectin Therapeutics is developing novel monoclonal antibodies directed towards Nectin receptors and ligands, playing major roles in immune checkpoint mechanisms relevant for cancer immune ...

Company Name NeoProl Year Company was Founded 2014 Company Founders Prof. Nissim Garti About the Company Established by Integra Holdings in 2014, NP-09 is at advanced preclinical development of an improved formulation of Propfol, based on ...

Company Name NrgStorEdge Ltd Company Founders Asa Ziv Prof. Yoel Sasson Current CEO Asa Ziv About the Company NrgStorEdge Ltd is a start-up, based on patented energy storage technology for safe and inexpensive use in zero-emission ...

Company Profile OnTimeBio is a cross-indication liquid biopsy (blood test) used to identify disease before symptoms appear. It is valid for cancer, neurological, metabolic, autoimmune, inflammatory and cardiovascular diseases A liquid biopsy is ...

AT A GLANCE Established by Integra Holdings and XL Vision Sciences, fully owned by BioLight Lifesciences Investments, in 2014, OPhRx is developing novel drug products for topical administration for diseases involving front-of the eye and back of ...

Computing Smart Peptides About us: Pepticom Ltd. is an Israeli innovative computational drug discovery company founded on December 2011, privately co-owned by the Hebrew University of Jerusalem, seed investors and the scientific team that ...

Company Name Qed-it Company Founders Prof. Aviv Zohar, Jonathan Rouach Current CEO Jonathan Rouach About the Company Founded by a world class team, QED-it has developed the Zero-Knowledge Blockchain. Combining two advanced technologies, ...

 About the company Raziel Therapeutics is a clinical-stage pharmaceutical company developing a proprietary drug (NCE) that after a single injection into subcutaneous fat, converts white adipose tissue (WAT) into thermogenic, brown-like adipose ...

  Company Name Seevix Company Founders Dr. Shlomzion Shen, CEO; Dr. Shmulik Ittah, CTO and Founder Current CEO Dr. Shlomzion Shen About the Company Seevix is a privately held biotech company producing high-strength, biocompatible spidersilk ...

Company Name Smart Resilin Company Founders Miki Tunis, Shmil Sachar Current CEO Shmil Sachar About the Company Smart Resilin’s Technology combines the strongest material produced by the plant ki Smart Resilin’s Technology combines the strongest ...

Company Name SolCold Year Company was founded Company Founders Yaron Shenhav Gadi Grottas About the Company SOLCOLD – NATURALLY COOL SUNLIGHT THE SUN ITSELF COULD SOON BECOME A LOW-COST AIR CONDITIONER… THE SUN - WHILE IT IS OUR BIGGEST SOURCE ...

Company Profile Splisense is developing targeted therapies for genetic diseases based on splicing modulation treating the underlying root cause of the disease.   SpliSense’s initial focus is on Cystic Fibrosis. SpliSense is developing a new ...

Company Name Ripples Company Founders Yossi Meshulam Eyal Eliav Danny Lavie Current CEO Yossi Meshulam About the Company Ripples helps you deliver daily smiles to customers by adding fun, personalized images to their beverage, generating an ...

Mechanism-Based Anti-Angiogenic Drug-Combination to Treat Cancer Tiltan Pharma is a start up company that developed a novel treatment for cancer which is now at  a phase-II clinical study in metastatic pancreatic cancer. The company has ...

Company Profile Tissue Dynamics Ltd. is a groundbreaking biotechnology company advancing smart microphysiological platforms for drug, food, and cosmetic development. The company’s proprietary tissue-embedded micro sensors permit real time ...

The Challenge Drug resistance is a major cause for failure of cancer chemotherapy. In present clinical practice, resistance to chemotherapy can only be recognized after the first course of treatment has been completed, yielding no major clinical ...